Search

Search Constraints

You searched for: Author/Creator Marks, Philippa

Search Results

1. Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy. (2nd November 2019)

2. Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO‐C): An open‐label, single‐arm, phase 4, multicentre trial. Issue 2 (15th March 2020)

3. Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study. Issue 12 (18th September 2019)

4. Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay. (9th March 2018)

5. Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study. (July 2017)

6. Hepatitis C virus‐specific immune responses following direct‐acting antivirals administered during recent hepatitis C virus infection. Issue 1 (13th November 2022)

7. Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study. (4th October 2019)

8. Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct‐acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort. Issue 5 (18th August 2022)

9. Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study. (18th May 2020)

10. Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs. (12th March 2020)